X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (932) 932
Publication (141) 141
Conference Proceeding (24) 24
Newspaper Article (14) 14
Book / eBook (9) 9
Patent (6) 6
Web Resource (5) 5
Book Chapter (3) 3
Book Review (2) 2
Dissertation (2) 2
Magazine Article (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (318) 318
humans (306) 306
male (275) 275
female (256) 256
middle aged (199) 199
cardiac & cardiovascular systems (189) 189
aged (156) 156
animals (92) 92
adult (82) 82
myocardial infarction (82) 82
analysis (80) 80
treatment outcome (72) 72
mortality (70) 70
surgery (70) 70
risk factors (62) 62
rats (59) 59
abridged index medicus (54) 54
care and treatment (54) 54
acute coronary syndromes (50) 50
therapy (50) 50
medicine, general & internal (49) 49
heart failure (47) 47
prospective studies (47) 47
heart attacks (46) 46
research (46) 46
cardiovascular (44) 44
double-blind method (43) 43
time factors (43) 43
drug therapy (42) 42
cardiac patients (40) 40
coronary heart disease (39) 39
follow-up studies (39) 39
clopidogrel (37) 37
medicine (37) 37
heart attack (36) 36
management (36) 36
prognosis (36) 36
rats, wistar (36) 36
aspirin (34) 34
diabetes (34) 34
health aspects (34) 34
medicine & public health (34) 34
patients (34) 34
aged, 80 and over (33) 33
peripheral vascular disease (33) 33
risk (33) 33
disease (32) 32
inflammation (32) 32
myocardial infarction - drug therapy (32) 32
adolescent (31) 31
myocardial infarction - mortality (31) 31
internal medicine (30) 30
cardiology (29) 29
cardiovascular disease (29) 29
usage (29) 29
cardiovascular diseases (27) 27
dentistry (27) 27
infectious diseases (27) 27
lasers (26) 26
medical research (26) 26
outcomes (26) 26
prevention (26) 26
brazil (25) 25
clinical trials (25) 25
platelet aggregation inhibitors - therapeutic use (25) 25
acute coronary syndrome (24) 24
coronary vessels (24) 24
engineering, biomedical (24) 24
medical and health sciences (24) 24
medicin och hälsovetenskap (24) 24
medicine, experimental (24) 24
patient outcomes (24) 24
stroke (24) 24
acute coronary syndrome - drug therapy (23) 23
atherosclerosis (23) 23
coronary artery disease (23) 23
microbiology (23) 23
pharmacology & pharmacy (23) 23
retrospective studies (23) 23
electrocardiography (22) 22
risk assessment (22) 22
studies (22) 22
ticagrelor (22) 22
association (21) 21
diagnosis (21) 21
exercise (21) 21
mice (21) 21
myocardial infarction - diagnosis (21) 21
myocardial-infarction (21) 21
cells (20) 20
child (20) 20
dentistry, oral surgery & medicine (20) 20
diabetes mellitus (20) 20
drug therapy, combination (20) 20
environmental sciences (20) 20
heart (20) 20
methods (20) 20
parasitology (20) 20
survival analysis (20) 20
thrombolysis (20) 20
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (5) 5
Engineering & Comp. Sci. - Stacks (2) 2
Gerstein Science - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Robarts - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Arquivos Brasileiros de Cardiologia, ISSN 0066-782X, 04/2007, Volume 88, Issue 1, pp. 2 - 19
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2016, Volume 67, Issue 23, pp. 2719 - 2728
Peripheral artery disease (PAD) is associated with heightened ischemic and bleeding risk in patients with prior myocardial infarction (MI). This study... 
peripheral arterial disease | ticagrelor | major adverse cardiovascular events | major adverse limb events | acute limb ischemia | CARDIAC & CARDIOVASCULAR SYSTEMS | ATHEROTHROMBOSIS | TRA2-DEGREES-P-TIMI 50 | OUTPATIENTS | RISK | STROKE | HEART-ATTACK | INTEGRATED DISCRIMINATION | CHARISMA TRIAL | THROMBOLYSIS | NET RECLASSIFICATION | Myocardial Infarction - epidemiology | Purinergic P2Y Receptor Antagonists - administration & dosage | Vascular Grafting - statistics & numerical data | Humans | Middle Aged | Male | Secondary Prevention | Ischemia - prevention & control | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Purinergic P2Y Receptor Antagonists - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Female | Stroke - epidemiology | Lower Extremity - surgery | Drug Therapy, Combination | Stroke - prevention & control | Hemorrhage - epidemiology | Ischemia - epidemiology | Adenosine - administration & dosage | Peripheral Arterial Disease - epidemiology | Adenosine - analogs & derivatives | Ischemia - surgery | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Lower Extremity - blood supply | Prevention | Medical colleges | Care and treatment | Ischemia | Cardiology | Heart attack | Heart failure | Anticoagulants | Aspirin | Stroke | Heart attacks | Heart surgery | Mortality | Cardiovascular disease | Confidence intervals | Disease prevention | Coronary vessels | Amputation | Chronic obstructive pulmonary disease | Diabetes | Kardiologi | Cardiac and Cardiovascular Systems | acute limb ischemia; major adverse cardiovascular events; major adverse limb events; peripheral arterial disease; ticagrelor
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1297 - 1309
Journal Article
Religião e Sociedade, ISSN 1984-0438, 06/2015, Volume 35, Issue 1, pp. 13 - 43
Resumo O artigo apresenta uma análise histórica da vida do liberto africano José Pedro Autran, casado, na Bahia, com Iyá Nassô, a fundadora do candomblé da... 
retornados/agudás | religiões afro-atlânticas | africanos libertos | redes de sociabilidade | Xangô
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 18, pp. 1702 - 1711
Darapladib, an oral inhibitor of lipoprotein-associated phospholipase A2, was compared with placebo in 15,828 patients with stable coronary heart disease.... 
TRIAL | LIPOPROTEIN | MEDICINE, GENERAL & INTERNAL | THERAPY | ACTIVATING-FACTOR ACETYLHYDROLASE | OXIDIZED LDL | RISK | PHOSPHOLIPASE A | ATHEROSCLEROTIC PLAQUE | INHIBITOR | CLINICAL-OUTCOMES | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Phospholipase A2 Inhibitors - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Oximes - administration & dosage | Male | Coronary Artery Disease - drug therapy | Coronary Disease - mortality | Phospholipase A2 Inhibitors - adverse effects | Benzaldehydes - adverse effects | Benzaldehydes - administration & dosage | Coronary Artery Disease - complications | Treatment Failure | Coronary Disease - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Prevention | Care and treatment | Ischemia | Dosage and administration | Research | Coronary heart disease | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Phospholipase A2 | Clinical trials | Myocardial ischemia | Cardiovascular disease | Angina | Preventive medicine | Coronary artery disease | Phospholipase | Arteriosclerosis | Death | Plasma levels | Drug therapy | Heart diseases | Plaques | Malalties cardiovasculars | Infart de miocardi | Malalties coronàries | Assaigs clínics de medicaments | Cardiovascular diseases | Drug testing | Coronary diseases | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 15, pp. 1404 - 1413
Patients with atherosclerotic vascular disease were randomly assigned to receive the thrombin antagonist vorapaxar or placebo. Vorapaxar reduced the rate of... 
ATOPAXAR | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | EFFICACY | SAFETY | TOLERABILITY | DOUBLE-BLIND | PRASUGREL | LESSONS | ANTAGONISTS | ASPIRIN | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Computer Science | Medical Imaging
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2019, Volume 381, Issue 14, pp. 1309 - 1320
Patients with stable coronary artery disease and diabetes were randomly assigned to receive either ticagrelor plus aspirin or placebo plus aspirin. At 40... 
MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | DUAL ANTIPLATELET THERAPY | MYOCARDIAL-INFARCTION | CARDIOVASCULAR EVENTS | CLINICAL BENEFIT | PLATELET INHIBITION | PRASUGREL | COLLABORATIVE METAANALYSIS | SECONDARY PREVENTION | 60 MG | Myocardial Infarction - epidemiology | Follow-Up Studies | Humans | Middle Aged | Hemorrhage - mortality | Male | Incidence | Drug Therapy, Combination - adverse effects | Ticagrelor - adverse effects | Aspirin - adverse effects | Female | Stroke - epidemiology | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor - therapeutic use | Diabetes Mellitus, Type 2 - complications | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Hemorrhage - epidemiology | Kaplan-Meier Estimate | Treatment Outcome | Coronary Artery Disease - drug therapy | Coronary Artery Disease - mortality | Coronary Artery Disease - complications | Diabetes Mellitus, Type 2 - mortality | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Control | Usage | Safety and security measures | Diabetes | Cardiovascular diseases | Drug therapy | Ticagrelor | Coronary heart disease | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Diabetes mellitus | Coronary artery | Cardiovascular disease | Thrombosis | Hemorrhage | Thrombolysis | Bleeding | Design | Ischemia | Blood platelets | Coronary vessels | Population | Diabetes mellitus (non-insulin dependent) | Heart diseases | Research centers | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 15, pp. 1493 - 1499
Journal Article